Zurcher Kantonalbank (Zurich Cantonalbank) Coll Plant Biotechnologies LTD Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$30.1 Billion
Q2 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	SELL	$4.97 - $6.64 $253 - $338	-51 Reduced 0.22%	23,089 $147,000
Q3 2023 Oct 25, 2023	SELL	$5.4 - $8.05 $167 - $249	-31 Reduced 0.13%	23,140 $128,000
Q2 2023 Aug 07, 2023	BUY	$6.6 - $8.23 $336 - $419	51 Added 0.22%	23,171 $189,000
Q1 2023 May 08, 2023	SELL	$6.74 - $12.99 $471 - $909	-70 Reduced 0.3%	23,120 $162,000
Q3 2022 Nov 09, 2022	SELL	$6.3 - $9.99 $126 - $199	-20 Reduced 0.09%	23,190 $159,000
Q2 2022 Aug 09, 2022	BUY	$8.0 - $11.19 $185,680 - $259,719	23,210 New	23,210 $189,000
Q1 2022 Apr 21, 2022	SELL	$8.97 - $16.4 $220,868 - $403,817	-24,623 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$12.0 - $22.48 $295,476 - $553,525	24,623 New	24,623 $403,000

Others Institutions Holding CLGN

# of Institutions

Shares Held

1.95M

Call Options Held

Put Options Held

View Full List

About CollPlant Biotechnologies Ltd

Ticker CLGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,086,500
Market Cap $54.7M
Description
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...

More about CLGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account